1. Home
  2. CGON vs CWH Comparison

CGON vs CWH Comparison

Compare CGON & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • CWH
  • Stock Information
  • Founded
  • CGON 2010
  • CWH 1966
  • Country
  • CGON United States
  • CWH United States
  • Employees
  • CGON N/A
  • CWH N/A
  • Industry
  • CGON
  • CWH Retail-Auto Dealers and Gas Stations
  • Sector
  • CGON
  • CWH Consumer Discretionary
  • Exchange
  • CGON NYSE
  • CWH Nasdaq
  • Market Cap
  • CGON 1.3B
  • CWH 1.2B
  • IPO Year
  • CGON 2024
  • CWH 2016
  • Fundamental
  • Price
  • CGON $23.74
  • CWH $14.69
  • Analyst Decision
  • CGON Strong Buy
  • CWH Strong Buy
  • Analyst Count
  • CGON 11
  • CWH 8
  • Target Price
  • CGON $62.90
  • CWH $21.88
  • AVG Volume (30 Days)
  • CGON 2.0M
  • CWH 3.2M
  • Earning Date
  • CGON 05-20-2025
  • CWH 04-29-2025
  • Dividend Yield
  • CGON N/A
  • CWH 3.38%
  • EPS Growth
  • CGON N/A
  • CWH N/A
  • EPS
  • CGON N/A
  • CWH N/A
  • Revenue
  • CGON $1,139,000.00
  • CWH $6,149,481,000.00
  • Revenue This Year
  • CGON N/A
  • CWH $7.53
  • Revenue Next Year
  • CGON $16,237.24
  • CWH $8.16
  • P/E Ratio
  • CGON N/A
  • CWH N/A
  • Revenue Growth
  • CGON 461.08
  • CWH 0.75
  • 52 Week Low
  • CGON $14.80
  • CWH $11.17
  • 52 Week High
  • CGON $40.47
  • CWH $25.97
  • Technical
  • Relative Strength Index (RSI)
  • CGON 49.91
  • CWH 54.58
  • Support Level
  • CGON $21.00
  • CWH $11.31
  • Resistance Level
  • CGON $30.23
  • CWH $14.34
  • Average True Range (ATR)
  • CGON 2.33
  • CWH 0.73
  • MACD
  • CGON 0.06
  • CWH 0.36
  • Stochastic Oscillator
  • CGON 30.94
  • CWH 95.05

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is retailer of RVs and related products and services. The Company has the two reportable segments: Good Sam Services and Plans segment includes sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories. RV and Outdoor Retail segment includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, sale of outdoor products, equipment, gear and supplies; business to business distribution of RV furniture, etc.

Share on Social Networks: